Evidence map›Paper›PMID 23881412›Full record

ReviewThe Plant cell2013

Biogenesis, turnover, and mode of action of plant microRNAs.

Kestrel Rogers, Xuemei Chen

Open access · bronzeAbstract readReview
In one paragraph

Review in The Plant cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 462 papers.

0numbers the graph read from it
0cells of the map it votes in
462citing papers in PubMed
102.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

462 citing papers in PubMed, 933 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. MsmiR171 targetsHorticulture research · 2026
    Article
  13. Review
  14. Small RNA mobility and plant virus diseases.Journal of experimental botany · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

402 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kestrel RogersDepartment of Botany and Plant Sciences, Institute of Integrative Genome Biology, University of California, Riverside, CA 92521, USA.
Xuemei Chen
Howard Hughes Medical Institute · USUniversity of California, Riverside · US

Funding

Regulation of APETALA2 in flower development in ArabidopsisR01GM061146 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI CHEN, MENG · 2000 to 2022
$6.5M
Howard Hughes Medical InstituteNIGMS NIH HHS GM061146NIGMS NIH HHS R01 GM061146
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small RNAs that control gene expression through silencing of target mRNAs. Mature miRNAs are processed from primary miRNA transcripts by the endonuclease activity of the DICER-LIKE1 (DCL1) protein complex. Mechanisms exist that allow the DCL1 complex to precisely excise the miRNA from its precursor. Our understanding of miRNA biogenesis, particularly its intersection with transcription and other aspects of RNA metabolism such as splicing, is still evolving. Mature miRNAs are incorporated into an ARGONAUTE (AGO) effector complex competent for target gene silencing but are also subjected to turnover through a degradation mechanism that is beginning to be understood. The mechanisms of miRNA target silencing in plants are no longer limited to AGO-catalyzed slicing, and the contribution of translational inhibition is increasingly appreciated. Here, we review the mechanisms underlying the biogenesis, turnover, and activities of plant miRNAs.

Indexed as

Argonaute ProteinsGene Expression Regulation, PlantMicroRNAsModels, GeneticPlantsRibonuclease IIIRNA, MessengerRNA, PlantRNA PrecursorsRNA Processing, Post-TranscriptionalArgonaute ProteinsMicroRNAsRibonuclease IIIRNA, MessengerRNA, PlantRNA Precursors

Identifiers

PMID23881412
PMCPMC3753372
OpenAlexW2042325491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.